Markéta Šuráňová

Markéta Šuráňová

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TKTomáš Krajňák
Tomáš Krajňák
EČEva Černá
Eva Černá
MŠMarkéta Šuráňová
Markéta Šuráňová
TSTomas Samoril
Tomas Samoril
DZDaniel Zicha
Daniel Zicha
JČJan Čechal
Jan Čechal
Biomimicking native tissues and organs require the development of advanced hydrogels. The patterning of hydrogel surfaces may enhance the cellular functionality and therapeutic efficacy of implants. For example, nanopatterning of the intraocular lens (IOL) surface can suppress the upregulation of cytoskeleton proteins (actin and actinin) within the cells in contact with the IOL surface and, hence, prevent secondary cataracts causing blurry or opaque vision. Here we introduce a fast and efficient method for fabricating arrays consisting of millions of individual nanostructures on the hydrogel surface. In particular, we have prepared the randomly distributed nanopillars on poly(2-hydroxyethyl methacrylate) hydrogel using replica molding and show that the number, shape, and arrangement of nanostructures are fully adjustable. Characterization by atomic force microscopy revealed that all nanopillars were of similar shape, narrow size distribution, and without significant defects. In imprint lithography, choosing the appropriate hydrogel composition is critical. As hydrogels with imprinted nanostructures mimic the natural cell environment, they can find applications in fundamental cell biology research, e.g., they can tune cell attachment and inhibit or promote cell clustering by a specific arrangement of protrusive nanostructures on the hydrogel surface.

16 May 2023 in Biomedical Optics Express
Verified
Journal Article
Open access
MŠMarkéta Šuráňová
Markéta Šuráňová
MĎMiroslav Ďuriš
Miroslav Ďuriš
INIrena Štenglová Netíková
Irena Štenglová Netíková
JBJan Brábek
Jan Brábek
THTomáš Horák
Tomáš Horák
PVPavel Veselý
Pavel Veselý
Solid tumor metastases cause most cancer-related deaths. The prevention of their occurrence misses suitable anti-metastases medicines newly labeled as migrastatics. The first indication of migrastatics potential is based on an inhibition of in vitro enhanced migration of tumor cell lines. Therefore, we decided to develop a rapid test for qualifying the expected migrastatic potential of some drugs for repurposing. The chosen Q-PHASE holographic microscope provides reliable multifield time-lapse recording and simultaneous analysis of the cell morphology, migration, and growth. The results of the pilot assessment of the migrastatic potential exerted by the chosen medicines on selected cell lines are presented.

24 February 2023 in Optica Open
Verified
Preprint
Open access
PDF file
MŠMarkéta Šuráňová
Markéta Šuráňová
MDMiroslav Duris
Miroslav Duris
INIrena Stenglova Netikova
Irena Stenglova Netikova
JBJan Brabek
Jan Brabek
THTomas Horak
Tomas Horak
PVPavel Vesely
Pavel Vesely
Solid tumor metastases cause most deaths. Prevention of their occurrence misses suitable anti-metastases medication. Migrastatics is the answer based on the link between the in vivo metastatic activity and the in vitro enhanced migration of cancer cells. Therefore, we decided to develop a rapid test for qualifying the expected migrastatic potential of some medicines suitable for repurposing. The chosen holographic microscope Q-PHASE provides reliable multifield time-lapse recording and simultaneous analysis of the cell morphology, migration, and growth. The results of the methodology of primary assessment of the migrastatic potential exerted by the selected medicines on preferred cancer cell lines are presented.

24 February 2023 in Optica Open
Verified
Preprint
Open access
PDF file
MŠMarkéta Šuráňová
Markéta Šuráňová
MDMiroslav Duris
Miroslav Duris
INIrena Stenglova Netikova
Irena Stenglova Netikova
JBJan Brabek
Jan Brabek
THTomas Horak
Tomas Horak
PVPavel Vesely
Pavel Vesely
Solid tumor metastases cause most deaths. Prevention of their occurrence misses suitable anti-metastases medication. Migrastatics is the answer based on the link between the in vivo metastatic activity and the in vitro enhanced migration of cancer cells. Therefore, we decided to develop a rapid test for qualifying the expected migrastatic potential of some medicines suitable for repurposing. The chosen holographic microscope Q-PHASE provides reliable multifield time-lapse recording and simultaneous analysis of the cell morphology, migration, and growth. The results of the methodology of primary assessment of the migrastatic potential exerted by the selected medicines on preferred cancer cell lines are presented.

1 January 2021
Verified
Conference Paper
Closed access
PDF file
MŠMarkéta Šuráňová
Markéta Šuráňová
DZDaniel Zicha
Daniel Zicha
PVPavel Veselý
Pavel Veselý
JBJan Brábek
Jan Brábek
VJVeronika Jůzová
Veronika Jůzová
RCRadim Chmelík
Radim Chmelík
Live lung cancer cells in vitro were exposed to selected medicaments with putative anti- metastatic potential and examined by time-lapse hiQPI, providing simultaneous measurements of the effect on cell growth and motility with unprecedented accuracy.